Offering biomedical innovators the experience, expertise, and funding required for success.
Through the RCT Ventures program, venture capital is provided to start-up or early-stage companies with technologies that have the potential to become significant biomedical products with a definite competitive edge. Learn more ›
RCT develops and invests in technologies that enhance and enable the discovery and manufacture of therapeutics and diagnostics. Many of these life science tools are available from RCT through affordable nonexclusive licensing. Learn more ›
Company completes 3rd acquisition and attracts growth equity investment for further expansion ARLINGTON, Va. (PRWEB) November 02, 2018 BioInformatics, a leading strategic services company for the life science, clinical diagnostics, analytical instrumentation, radiology, and dental markets, announced today a $21 … Learn more